| Literature DB >> 27071614 |
Ewelina Król1, Magdalena Jeszka-Skowron2, Zbigniew Krejpcio3, Ewa Flaczyk4, Rafał W Wójciak5.
Abstract
Mulberry leaves (Morus alba) have been used in folk medicine to mitigate symptoms of diabetes. The mulberry plant contains phenolic compounds that are able to decrease blood glucose concentration. Since various phenolics have antioxidant and metal binding properties, they can be used to alleviate oxidative stress and chelate trace elements involved in redox reactions. The aim of this study was to evaluate the effects of dietary supplementation with mulberry leaf extracts (acetone-water (AE) and ethanol-water (EE)) on the trace element status (Fe, Zn and Cu) in relation to diabetes management and antioxidant indices in high-fat diet-fed/STZ diabetic rats. The experiment was performed on 38 male Wistar rats with diabetes (induced by high-fat diet (HF) and streptozotocin injection) or the control fed with AIN-93M or high-fat diet. As a result, five experimental groups were used: (1) a healthy control group fed with AIN-93M; (2) an HF control group; (3) a diabetic HF group; (4) a diabetic HF + AE group (6 g/kg diet); (5) a diabetic HF + EE group (6 g/kg diet). The rats were fed with appropriate diets for 4 weeks. The content of trace elements (Fe, Zn and Cu) in the serum and tissues was measured by means of atomic absorption spectrometry (AAS). Biochemical analyses (glucose, TBARS, FRAP) were performed on the blood serum. It was shown that the AE decreased hepatic and renal Fe stores, while the EE increased hepatic Cu levels in diabetic rats and confirmed their ability to regulate the Fe and Cu status in diabetes. The results confirmed a significant hypoglycaemic and antioxidant potential of both mulberry leaf extracts in diabetic rats.Entities:
Keywords: Diabetes; Mulberry leaf extracts; Rats; Trace elements
Mesh:
Substances:
Year: 2016 PMID: 27071614 PMCID: PMC5055558 DOI: 10.1007/s12011-016-0696-1
Source DB: PubMed Journal: Biol Trace Elem Res ISSN: 0163-4984 Impact factor: 3.738
The composition of experimental diets
|
|
|
| ||
|---|---|---|---|---|
|
|
|
| ||
| Casein | 140.0 | 140.0 | 140.0 | 140.0 |
| Lard | 0.0 | 150.0 | 150.0 | 150.0 |
| Sunflower oil | 70.0 | 100.0 | 100.0 | 100.0 |
| Wheat starch | 592.0 | 412.0 | 406.0 | 406.0 |
| Sucrose | 100.0 | 100.0 | 100.0 | 100.0 |
| Potato starch | 50.0 | 50.0 | 50.0 | 50.0 |
| Mineral mixturea | 35.0 | 35.0 | 35.0 | 35.0 |
| Vitamin mixtureb | 10.0 | 10.0 | 10.0 | 10.0 |
| L-cystine | 3.0 | 3.0 | 3.0 | 3.0 |
| Acetone extract (AE) | 0.0 | 0.0 | 6.0 | 0.0 |
| Ethanol extract (EE) | 0.0 | 0.0 | 0.0 | 6.0 |
aMineral mixture was prepared according to AIN-93 M recommendation [29]
bVitamin mixture was prepared according to AIN-93 M recommendation [29]
The content of minerals in Morus alba leaves extracts (mg/100 g dry matter)
| Item |
| |
|---|---|---|
| AE (65 % acetone–water) | EE (65 % ethanol–water) | |
| Fe | 1.163 ± 0.008a | 2.783 ± 0.040b |
| Zn | 7.439 ± 0.338b | 4.500 ± 0.088a |
| Cu | 0.344 ± 0.001a | 1.249 ± 0.013b |
Data are mean ± SEM; means in a row with different letters differ significantly (p < 0.05)
Nutritional and blood biochemical indices in rats
| Index | Experimental group | ||||
|---|---|---|---|---|---|
| No-DB/control (C) | No-DB/HF-no treatment | DB/HF-no-treatment | DB/HF-AE | DB/HF + EE | |
| Diet intake (g dm/day) | 20.20 ± 0.45b | 16.79 ± 0.59a | 16.96 ± 0.60a | 17.85 ± 0.35a | 16.84 ± 6.87a |
| Dietary total phenolics intake (mg GAE/kg bw/day) | − | − | − | 24.83 ± 0.19a | 31.57 ± 0.19b |
| Dietary total flavonoids intake (mg QUE/kg bw/day) | − | − | − | 10.63 ± 0.23a | 13.05 ± 0.22b |
| Chlorogenic acid intake (mg/kg bw/day) | − | − | − | 1.76 ± 0.08a | 3.76 ± 0.03b |
| Quercetin 3-(6-malonylglucoside) intake (mg/kg bw/day) | − | − | − | 2.45 ± 0.03a | 3.38 ± 0.02b |
| Rutin intake (mg/kg bw/day) | − | − | − | 1.22 ± 0.01a | 1.68 ± 0.01b |
| Serum Fe (μmol/L) | 30.95 ± 3.50 | 37.86 ± 3.51 | 35.71 ± 3.66 | 35.88 ± 5.24 | 26.13 ± 4.28 |
| Serum Zn (μmol/L) | 20.00 ± 0.76bc | 16.62 ± 0.62ab | 15.94 ± 0.88a | 17.15 ± 0.58ab | 16.11 ± 0.50ab |
| Serum Cu (mmol/L) | 16.72 ± 0.47 | 14.69 ± 0.48 | 14.97 ± 1.42 | 14.88 ± 0.53 | 15.52 ± 0.52 |
| Serum Zn/Cu (molar ratio) | 1.20 ± 0.05 | 1.14 ± 0.07 | 1.11 ± 0.05 | 1.16 ± 0.04 | 1.05 ± 0.06 |
| Serum TBARS (μmol TMP/L) | 8.71 ± 0.28 a | 17.91 ± 4.48ab | 22.52 ± 4.83b | 11.39 ± 1.28a | 11.12 ± 0.89a |
| Serum FRAP (μmol FeSO4/L) | 383.93 ± 13.75c | 320.05 ± 20.92ab | 323.64 ± 7.39ab | 307.64 ± 14.41a | 350.34 ± 14.47abc |
| Serum insulin (pmol/L) | 478.51 ± 32.67b | 369.05 ± 20.29b | 130.54 ± 4.78a | 479.52 ± 88.54ab | 374.10 ± 36.28b |
Data are mean ± SEM; means in a row with different letters differ significantly (p < 0.05)
TBARS thiobarbituric acid reactive substances, TMP 1,1,3,3-tetramethoxypropane, DNJ 1-deoxynojirimycin, FRAP ferric reducing ability of plasma
Fig. 1Plasma glucose concentration at the end of the experiment. Data are mean ± SEM; bars with different letters differ significantly (p < 0.05).
The content of microelements (Fe, Zn and Cu; in μg/g dry matter) in tissues of experimental rats
| Mineral content (μg/g dm) | Experimental group | |||||
|---|---|---|---|---|---|---|
| No-DB/control (C) | No-DB/HF-no treatment | DB/HF-no-treatment | DB/HF-AE | DB/HF + EE | ||
| Fe | Liver | 266.31 ± 19.10a | 424.64 ± 24.72b | 415.14 ± 23.39b | 313.63 ± 24.51a | 338.46 ± 15.45ab |
| Kidneys | 298.31 ± 10.41ab | 257.84 ± 3.70a | 369.67 ± 16.16b | 288.67 ± 13.12a | 304.24 ± 11.65ab | |
| Spleen | 3705.4 ± 214.65 | 3697.5 ± 108.91 | 3612.8 ± 469.19 | 2661.8 ± 279.29 | 3368.5 ± 286.15 | |
| Zn | Liver | 96.79 ± 3.07 | 90.87 ± 3.81 | 97.07 ± 1.77 | 95.25 ± 2.44 | 107.07 ± 3.21 |
| Kidneys | 99.78 ± 2.22 | 86.47 ± 3.97 | 100.43 ± 3.20 | 103.04 ± 5.24 | 101.73 ± 5.01 | |
| Spleen | 80.83 ± 2.63 | 83.64 ± 2.55 | 88.26 ± 1.15 | 83.09 ± 2.56 | 81.26 ± 1.11 | |
| Cu | Liver | 18.93 ± 0.78ab | 15.73 ± 0.86a | 18.28 ± 0.29a | 17.75 ± 0.94a | 22.35 ± 1.12b |
| Kidneys | 39.77 ± 2.01b | 29.77 ± 2.58a | 45.25 ± 5.34b | 42.98 ± 2.49b | 43.59 ± 4.25b | |
| Spleen | 10.52 ± 0.75 | 12.64 ± 0.44 | 17.00 ± 2.80 | 17.78 ± 2.59 | 8.88 ± 1.62 | |
| Zn/Cu (molar ratio) | Liver | 5.07 ± 0.18ab | 5.71 ± 0.16 b | 5.24 ± 0.12ab | 5.32 ± 0.29ab | 4.55 ± 0.19a |
| Kidneys | 2.49 ± 0.08 | 2.98 ± 0.24 | 2.56 ± 0.23 | 2.37 ± 0.23 | 2.32 ± 0.19 | |
| Spleen | 8.02 ± 0.54 | 6.53 ± 0.30 | 6.12 ± 0.83 | 6.60 ± 1.22 | 10.49 ± 1.40 | |
Data are mean ± SEM; means in a row with different letters differ significantly (p < 0.05)